
Now loading...
JM Financial recommends buying Sun Pharmaceutical Industries with a target of Rs 2094. Currently, Sun Pharma is priced at Rs 1824.1. Sun Pharma’s market growth is driven by volume and new product launches. Promoters hold 54.48 percent stake, and FIIs own 18 percent. The strategy involves expanding in Tier 2/3 cities and hiring more Medical Reps.
Now loading...